Salarius Pharmaceuticals Presents SP-3164 Preclinical Data
Preclinical data show synergistic activity for the targeted protein degrader SP-3164 with rituximab in non-Hodgkin’s
Globe Newswire27-01-2023, 20:39
Argentina’s CSD Caja de Valores Adopts Nasdaq Technology to Modernize the Country’s Post-Trade Infrastructure 11-01-2024, 16:00